Skip to main content
. 2022 Apr 22;12:6608. doi: 10.1038/s41598-022-10696-w

Table 1.

Clinical characteristics of patients with DV and controls.

DV group
(n = 43)
Control group
(n = 25)
P value
Age 54.0 ± 14.1 60.5 ± 10.6 0.069
IPSS-V 9.1 ± 7.2 1.4 ± 1.6  < 0.001
IPSS-S 6.0 ± 4.0 2.5 ± 2.0 0.001
IPSS 15.1 ± 9.9 3.9 ± 2.2  < 0.001
VUDS
  FSF 127.1 ± 54.4 164.6 ± 65.3 0.012
  Bladder compliance 77.6 ± 84.1 158.1 ± 93.7  < 0.001
  CBC 290.3 ± 125.6 379.0 ± 179.0 0.004
  Pdet 47.79 ± 42.74 14.62 ± 7.19 0.001
  Qmax 10.66 ± 6.85 19.41 ± 8.64  < 0.001
  cQmax 0.63 ± 0.37 0.91 ± 0.39  < 0.001
  Vol 232.7 ± 114.2 406.3 ± 143.7  < 0.001
  PVR 57.7 ± 66.2 5.7 ± 12.4  < 0.001
  VE 0.79 ± 0.23 0.98 ± 0.05  < 0.001
BOOIf 24.33 ± 47.82  − 30.41 ± 18.16  < 0.001

DV Dysfunctional voiding, IPSS International prostate symptom score, IPSS-S International prostate symptom score storage subscore, IPSS-V International prostate symptom score voiding subscore, VUDS Videourodynamic study, FSF First sensation of bladder filling, CBC Cystometric bladder capacity, Pdet Detrusor voiding pressure, Qmax Maximal urinary flow rate, cQmax Corrected maximal urinary flow rate, Vol Voided volume, PVR Post-void residual volume, VE Voiding efficacy, BOOIf Female bladder outlet obstruction index.